ℹ️
🇬🇧
Search
Search for publications relevant for "chorobu modifikující léky"
chorobu modifikující léky
Publication
Class
Person
Publication
Programmes
Export current view
publication
Disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis
2005 |
First Faculty of Medicine
publication
Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs
2012 |
First Faculty of Medicine
publication
Adverse Events of Drugs Used in Therapy or Rheumatic diseases - I. Disease Modifying drugs Used in the Therapy of Rheumatoid Arthritis and Basic Principals of Monitoring of Safety
2003 |
First Faculty of Medicine
publication
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration
2012 |
First Faculty of Medicine
publication
Mají inhibitory TNF stále místo v první linii léčby revmatoidní artritidy?
2021 |
First Faculty of Medicine
publication
The importance of subcutaneous methotrexate in the treatment of rheumatic diseases
2015 |
First Faculty of Medicine
publication
Methotrexate and its role in rheumatology daily practice
2019 |
First Faculty of Medicine
publication
News in the treatment of inflammatory arthropathies for general practitioners
2019 |
First Faculty of Medicine
publication
Current options for the treatment of psoriatic arthritis
2017 |
Faculty of Medicine in Hradec Králové
publication
What we can do for a patient with psoriatic arthritis when TNF inhibitors fail
2019 |
First Faculty of Medicine
publication
Main principles of pharmacotherapy of rheumatic diseases in old age
2019 |
First Faculty of Medicine
publication
Progressive multiple sclerosis in the light of the latest findings
2023 |
First Faculty of Medicine
publication
Leflunomide in the therapy of active rheumatoid arthritis
2004 |
First Faculty of Medicine
publication
The Czech Rheumatological Society recommendations for monitoring the treatment safety in rheumatoid arthritis.
2009 |
First Faculty of Medicine
publication
The role od Janus kinase inhibitors in the therapy of psoriatic arthritis
2023 |
First Faculty of Medicine
publication
Malé molekuly s velkými cíli - selektivní inhibice Janusovy kinázy 1 v terapii psoriatické artritidy
2023 |
First Faculty of Medicine
publication
Léčba revmatických onemocnění v průběhu gravidity a laktace
2021 |
First Faculty of Medicine
publication
Current approaches to giant cell arteriitis therapy
2019 |
First Faculty of Medicine
publication
Inhibice interleukinu 6 - moderní léčba obrovskobuněčné arteriitidy
2017 |
First Faculty of Medicine
publication
Tocilizumab in the treatment of rheumatoid arthritis
2017 |
First Faculty of Medicine
publication
Psoriatic arthritis news
2019 |
First Faculty of Medicine
publication
Current psoriatic arhtritis treatment options
2019 |
First Faculty of Medicine
publication
New view on interleukin-6 receptor blodkade in rheumatoid arthritis
2018 |
First Faculty of Medicine
publication
Is it possible to modify structural progression in patients with axial spondyloarthritis?
2019 |
First Faculty of Medicine
publication
Biologics in the treatment of rheumatoid arthritis
2014 |
First Faculty of Medicine
publication
Clinical farmakoiogie antirheumatic drugs
2015 |
Publication without faculty affiliation
publication
News in the biological treatment of psoriatic arthritis
2015 |
First Faculty of Medicine
publication
Obrovskobuněčná arteriitida - nové poznatky o diagnostice a léčbě
2019 |
First Faculty of Medicine
publication
Bechterew's disease : Instructions for active life and exercise guides
2018 |
Faculty of Physical Education and Sport
publication
Juvenile idiopatic arthritis associated uveitis
2018 |
First Faculty of Medicine